WASHINGTON (AP) - A panel of federal health experts on Tuesday overwhelmingly recommended approval for a long-acting inhaler to treat people suffering from chronic lung disease.The Food and Drug Administration panel voted 15-1, with one abstention, that Boehringer Ingelheim's once-daily Striverdi Respimat (STRIH-ver-dee Res-peh-mat) inhaler is safe and effective for ...